Kim L. Rice

1.1k total citations
17 papers, 777 citations indexed

About

Kim L. Rice is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kim L. Rice has authored 17 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Hematology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kim L. Rice's work include Acute Myeloid Leukemia Research (7 papers), Retinoids in leukemia and cellular processes (7 papers) and Epigenetics and DNA Methylation (4 papers). Kim L. Rice is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Retinoids in leukemia and cellular processes (7 papers) and Epigenetics and DNA Methylation (4 papers). Kim L. Rice collaborates with scholars based in United States, France and Australia. Kim L. Rice's co-authors include Jonathan D. Licht, Itsaso Hormaeche, Hugues de Thé, Julien Ablain, Saverio Minucci, Aurélien de Reyniès, Sergei Doulatov, John E. Dick, Wayne K. Greene and Arthur Zelent and has published in prestigious journals such as Nature Medicine, Genes & Development and Blood.

In The Last Decade

Kim L. Rice

17 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim L. Rice United States 12 550 254 115 112 98 17 777
Annette Orleth Italy 10 620 1.1× 403 1.6× 82 0.7× 196 1.8× 81 0.8× 14 843
Jörn Lausen Germany 18 670 1.2× 180 0.7× 110 1.0× 141 1.3× 96 1.0× 33 928
Munetake Shimabe Japan 11 498 0.9× 429 1.7× 68 0.6× 83 0.7× 182 1.9× 20 862
Sebastien A. Burel United States 15 972 1.8× 452 1.8× 128 1.1× 109 1.0× 149 1.5× 23 1.2k
Siân Rizzo United Kingdom 15 601 1.1× 179 0.7× 184 1.6× 301 2.7× 138 1.4× 25 1.1k
Sheryl M. Gough United States 12 477 0.9× 231 0.9× 62 0.5× 90 0.8× 66 0.7× 23 658
Margaret R. Hough Canada 13 644 1.2× 181 0.7× 122 1.1× 131 1.2× 198 2.0× 26 932
Hind Medyouf Germany 13 526 1.0× 247 1.0× 157 1.4× 298 2.7× 220 2.2× 23 976
Xonia Carvajal‐Vergara Spain 11 504 0.9× 281 1.1× 55 0.5× 184 1.6× 127 1.3× 18 736
M Allouche France 12 303 0.6× 141 0.6× 46 0.4× 124 1.1× 118 1.2× 25 583

Countries citing papers authored by Kim L. Rice

Since Specialization
Citations

This map shows the geographic impact of Kim L. Rice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim L. Rice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim L. Rice more than expected).

Fields of papers citing papers by Kim L. Rice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim L. Rice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim L. Rice. The network helps show where Kim L. Rice may publish in the future.

Co-authorship network of co-authors of Kim L. Rice

This figure shows the co-authorship network connecting the top 25 collaborators of Kim L. Rice. A scholar is included among the top collaborators of Kim L. Rice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim L. Rice. Kim L. Rice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Esnault, Cécile, Ramy Rahmé, Kim L. Rice, et al.. (2019). FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias. Blood. 133(13). 1495–1506. 32 indexed citations
2.
Barritault, Denis, Kim L. Rice, Dulce Papy-García, et al.. (2016). RGTA® or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients. Glycoconjugate Journal. 34(3). 325–338. 59 indexed citations
3.
Greene, Wayne K., et al.. (2015). Identification of genes associated with blood feeding in the cat flea, Ctenocephalides felis. Parasites & Vectors. 8(1). 368–368. 14 indexed citations
4.
Ablain, Julien, et al.. (2014). Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure. Nature Medicine. 20(2). 167–174. 141 indexed citations
5.
Rice, Kim L. & Hugues de Thé. (2014). The acute promyelocytic leukaemia success story: curing leukaemia through targeted therapies. Journal of Internal Medicine. 276(1). 61–70. 13 indexed citations
6.
Lin, Xiaoqing, Kim L. Rice, Monica Buzzai, et al.. (2012). miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation. Leukemia. 27(2). 344–352. 49 indexed citations
7.
Kentsis, Alex, Casie Reed, Kim L. Rice, et al.. (2012). Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia. Nature Medicine. 18(7). 1118–1122. 140 indexed citations
8.
Rice, Kim L., Xiaoqing Lin, Kristy Wolniak, et al.. (2011). Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms. Blood Cancer Journal. 1(11). e40–e40. 32 indexed citations
9.
Doulatov, Sergei, Faiyaz Notta, Kim L. Rice, et al.. (2009). PLZF is a regulator of homeostatic and cytokine-induced myeloid development. Genes & Development. 23(17). 2076–2087. 79 indexed citations
10.
Rice, Kim L., Mansour Heidari, Ross Taplin, Ursula R. Kees, & Wayne K. Greene. (2009). Transcriptional regulation of the human ALDH1A1 promoter by the oncogenic homeoprotein TLX1/HOX11. Hematology Reports. 1(2). 13–13. 2 indexed citations
11.
Rice, Kim L., Itsaso Hormaeche, Sergei Doulatov, et al.. (2009). Comprehensive genomic screens identify a role for PLZF-RARα as a positive regulator of cell proliferation via direct regulation of c-MYC. Blood. 114(27). 5499–5511. 43 indexed citations
12.
Hormaeche, Itsaso, Kim L. Rice, Arthur Zelent, Melanie J. McConnell, & Jonathan D. Licht. (2008). PLZF-RARα Utilizes the Histone Methyl Transferase G9a/GLP and the Histone Demethylase LSD1 to Repress RARα Target Genes and Block Myeloid Differentiation. Blood. 112(11). 198–198. 2 indexed citations
13.
Rice, Kim L., Ursula R. Kees, & Wayne K. Greene. (2007). Transcriptional regulation of FHL1 by TLX1/HOX11 is dosage, cell-type and promoter context-dependent. Biochemical and Biophysical Research Communications. 367(3). 707–713. 8 indexed citations
15.
Rice, Kim L., Itsaso Hormaeche, & Jonathan D. Licht. (2007). Epigenetic regulation of normal and malignant hematopoiesis. Oncogene. 26(47). 6697–6714. 116 indexed citations
16.
Heidari, Mansour, et al.. (2005). The nuclear oncoprotein TLX1/HOX11 associates with pericentromeric satellite 2 DNA in leukemic T-cells. Leukemia. 20(2). 304–312. 11 indexed citations
17.
Heidari, Mansour, Kim L. Rice, Ursula R. Kees, & Wayne K. Greene. (2002). Expression and purification of the human homeodomain oncoprotein HOX11. Protein Expression and Purification. 25(2). 313–318. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026